N23-29730-77655
3 vaccinations
1 coded response
34 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 683 / NE
- Registered
- 2021-06-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-17
Registered in v-safe
-
2021-06-17
Dose 1 — Pfizer-BioNTech
- 2021-06-17
- 2021-06-18
- 2021-06-19
- 2021-06-20
- 2021-06-22
- 2021-06-25
- 2021-07-01
-
2021-07-08
Dose 2 — Pfizer-BioNTech
- 2021-07-08
- 2021-07-09
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-22
- 2021-07-29
- 2021-08-05
- 2021-08-13
- 2021-08-19
- 2021-10-07
- 2022-01-06
-
2022-01-16
Dose 3 — Pfizer-BioNTech
-
2022-01-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-01-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2022-01-20
- 2022-01-27
- 2022-01-30
- 2022-02-06
- 2022-02-13
- 2022-02-20
- 2022-03-01
- 2022-04-17
-
2022-07-20
Survey response — 6 months, dose 3MedDRA: Cough, Lower respiratory tract infection, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Two severe head/chest colds. Tested negative for COVID multiple times with each. Sore throat, congestion, sneezing, coughing. No fever.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-17 | Pfizer-BioNTech | |
| 2 | 2021-07-08 | Pfizer-BioNTech | No |
| 3 | 2022-01-16 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3
Symptoms: Two severe head/chest colds. Tested negative for COVID multiple times with each. Sore throat, congestion, sneezing, coughing. No fever.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Lower respiratory tract infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release